NSC |
Compound |
Enrichment |
Correlation |
NSC 744622 |
4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide |
0.029334167004364 |
0.19890137 |
NSC 750717 |
5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one |
0.0293341670043648 |
0.39978491 |
NSC 752385 |
Null |
0.0293341670043648 |
0.50282833 |
NSC 751830 |
2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one |
0.0295480456086945 |
0.101999 |
NSC 102225 |
Null |
0.0295480456086947 |
0.41658791 |
NSC 132275 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.0295480456086947 |
0.2258684 |
NSC 13275 |
Null |
0.0295480456086947 |
0.43273429 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0295480456086947 |
0.37351436 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.0295480456086947 |
0.1005254 |
NSC 208885 |
Null |
0.0295480456086947 |
0.13349843 |